Work

Outcomes of Ibrutinib (Ibr) Therapy in Ibr-Naïve Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Progressing after Venetoclax (Ven)

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-123665

Authors: Jennifer R. Brown, Matthew S. Davids, Julie E Chang, Shuo Ma, Juliana M L Biondo, Yong Mun, Madlaina Breuleux, William G. Wierda

Institutions: Dana-Farber Cancer Institute, University of Wisconsin–Madison, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Genentech, F. Hoffmann-La Roche AG, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2987520201

Cites:

Cited by: 13

Related to: 10